Brainomix
PrivateLast Round
Series C
Extension
Feb 24, 2026
Total Funding Raised
$69.4M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Brainomix is a medical technology company that provides an AI-powered platform with imaging biomarkers to assist clinicians with diagnosis and treatment decisions for stroke, lung fibrosis, and cancer.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Brainomix Comparables
Compare Brainomix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RapidAI | 87% | |
| Nicolab | 85% | |
| Cercare Medical | 82% | |
Brainomix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Feb 24, 2026 | ||||
| Series C | Mar 18, 2025 | ||||
| Series C Extension | Feb 24, 2024 | ||||
| Grant | Oct 12, 2023 | ||||
| Series B | Dec 16, 2021 | ||||
Series A | Apr 3, 2018 |
Key People
Founding team and executive leadership
Brainomix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Boehringer Ingelheim | Series C |
| IP Group | Series C |
| Hostplus Superannuation Fund | Series C Extension, Series C |
| IP Group Australia | Series C Extension |
| Boehringer Ingelheim Venture Fund | Series A, Series B, Series C |
| Modi Ventures | Series C Extension, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors grew 30% MoM, reaching 10.8K.
- Apr 15, 2026
Monthly visitors increased 36% MoM to 11.5K.
Brainomix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Brainomix's valuation, stock price, and market status.